Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article Report
  • Published:

Revised diagnostic criteria for neuromyelitis optica—incorporation of NMO-IgG status

Nature Clinical Practice Neurology volume 3, page E1 (2007)Cite this article

Access through your institution
Buy or subscribe

Arising from: Hemmer B and Stüve O (2007) Revised criteria for neuromyelitis optica–a new diagnostic standard? Nat Clin Pract Neurol 3: 132–133 doi:10.1038/ncpneuro0420

We have read with interest the commentary by Bernhard Hemmer and Oliver Stüve regarding the recent proposal by Wingerchuk et al.1 to include NMO-IgG, a newly detected serum reactivity, in the diagnostic criteria for neuromyelitis optica (NMO). We share the commentary authors' concerns regarding the fact that this proposal was made prior to independent confirmation of the diagnostic sensitivity and specificity of the test.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wingerchuk DM et al. (2006) Revised diagnostic criteria for neuromyelitis optica Neurology 66: 1485–1489

    Article  CAS  Google Scholar 

  2. Jarius S et al. (2007) NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68: 1076–1077

    Article  CAS  Google Scholar 

  3. Lennon VA et al. (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106–2112

    Article  CAS  Google Scholar 

  4. Lennon VA et al. (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473–477

    Article  CAS  Google Scholar 

  5. Paul F et al. (2007) Antibody to aquaporin-4 in the diagnosis of neuromyelitis optica. PLOS Medicine 4: e133 doi:10.1371/journal.pmed.0040133

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, OX3 9DS, UK

    Sven Jarius, Friedemann Paul, Diego Franciotta, Orhan Aktas, Reinhard Hohlfeld, Frauke Zipp & Angela Vincent

Authors
  1. Sven Jarius
    View author publications

    Search author on:PubMed Google Scholar

  2. Friedemann Paul
    View author publications

    Search author on:PubMed Google Scholar

  3. Diego Franciotta
    View author publications

    Search author on:PubMed Google Scholar

  4. Orhan Aktas
    View author publications

    Search author on:PubMed Google Scholar

  5. Reinhard Hohlfeld
    View author publications

    Search author on:PubMed Google Scholar

  6. Frauke Zipp
    View author publications

    Search author on:PubMed Google Scholar

  7. Angela Vincent
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Angela Vincent.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jarius, S., Paul, F., Franciotta, D. et al. Revised diagnostic criteria for neuromyelitis optica—incorporation of NMO-IgG status. Nat Rev Neurol 3, E1 (2007). https://doi.org/10.1038/ncpneuro0501

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpneuro0501

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing